Oneness Biotech , Ltd.'s current cash is $360M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 4743.TWO shows a current cash of $360M. That compares with $2.9B in the prior-year period — down 87.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4743.TWO's current cash is now $360M (was $2.9B) — a 87.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Oneness Biotech , Ltd. is outperforming or lagging.
Tracking 4743.TWO's current cash over time shows whether Oneness Biotech , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $360M That compares with $2.9B in the prior-year period — down 87.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Oneness Biotech , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $360M) with ownership activity and broader fundamentals.
Oneness Biotech , Ltd.'s current cash is $360M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.